Until vaccines against COVID-19 become available, ‘testing, testing and more testing’ to support the detection of cases and isolation of patients is the only effective strategy against the disease.
Kunal Jain, from IMAP India’s team, summarises the pharmaceutical progress on treatments for Covid-19 and highlights from a recent virtual conference on this subject in Israel the steps being taken across the world on a possible cure to halt the spread of the virus.
Read the Chairman's Letter introduction to the Coronavirus special edition of IMAP's publication, Creating Value.
IMAP closed 49 M&A deals worth more than $1.4bn in Q1 2020. 43% of the deals were cross-border.
Last weekend, IMAP colleagues from all over the world were due to congregate in Denver, Colorado, for a conference planned for many months, where deals, learning, and friendships would be developed and shaped.
